![]() The Government said the new pilots will build on work to ‘tackle obesity, reducing pressure on the NHS and cutting waiting lists’. It said the drug should be prescribed to adults who have at least one weight-related comorbidity and a BMI of at least 35kg/m2, alongside a reduced-calorie diet and increased physical activity. In March, NICE recommended injectable prescription medication semaglutide (Wegovy) for use as part of a patient’s treatment in an NHS specialist weight management service and with the support of a multi-disciplinary team. ![]()
0 Comments
Leave a Reply. |